Manufacturing & Bioprocessing - software & AI news

Daily news on software, AI, and companies shaping manufacturing & bioprocessing.

Showing 98 results
Press release cover image

Oct 14, 2026

New York City Biotech Startups Neion Bio and Barnwell Bio Partner to Advance Biomanufacturing and Biosecurity

NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Neion Bio, a biotechnology company revolutionizing the production of biologic medicines, and Barnwell Bio, an animal health intelligence company, today announced a strategic collaboration under which Barnwell will provide biosurveillance to Neion to support proactive flock health and biosecurity across its avian operations. The collaboration brings together two New York City biotechnology companies that are applying frontier technologies to chicken b
Press release cover image

Oct 13, 2026

Analytics By Light Targets Morphology Blind Spot in Biomanufacturing

PELHAM, N.H., October 13, 2026 — Analytics By Light todayannounced its incorporation in Delaware as Analytics By Light, Inc. and hasappointed co-founder Phillip Maderia President and Chief Executive Officer. Thecompany is developing the µImager™ platform to give bioreactors continuous,in-situ visibility of cell morphology as the process unfolds.Conventional process analytical technology monitors thebioreactor environment, pH, oxygen, and temperature, but provides limitedvisibility of the cells t
Press release cover image

Oct 13, 2026

MasterControl Adds 90 New Customers in 2026 as Demand for Connected Quality and Manufacturing Accelerates

MES ARR grows 20% year over year; Quality Event Management usage up more than 70% in 2026SALT LAKE CITY, Oct. 13, 2026 /PRNewswire/ -- MasterControl, a leading provider of quality and manufacturing software solutions for the life sciences industry, announced today during its annual Masters Summit customer conference that it has experienced continued and strong business momentum in 2026. Driven by increasing demand for AI-powered operational efficiency, the company added 90 new customers year to
Minimalist illustration of RNA and factory

Oct 12, 2026

ARPA-H program manager talks 'first-shoring' philosophy behind $125M RNA manufacturing network challenge

The U.S. Advanced Research Projects Agency for Health (ARPA-H) is launching a $125 million initiative aimed at developing automated manufacturing systems for personalized RNA-based medicines. This initiative is part of their Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) program, which seeks to decentralize production, bringing it closer to patients.ARPA-H's focus on "first-shoring" emphasizes building manufacturing capabilities in anticipation of future needs, rather tha
Press release cover image

Oct 8, 2026

Seeq Collaborates with Cognizant to Accelerate Industrial AI Adoption in Life Sciences

SEATTLE, Oct. 8, 2026 /PRNewswire/ -- Seeq, a global leader in Industrial AI, today announced it is collaborating with Cognizant, an AI Builder and technology services provider, to help life sciences and pharmaceutical manufacturers move faster from data to action. By combining Seeq's advanced industrial AI and analytics with Cognizant's advisory, implementation, delivery, and change management capabilities, the companies intend to help customers scale manufacturing analytics and performance imp
Press release cover image

Oct 7, 2026

PharmaTher Launches M3DICINES(TM) National Network Program to Provide 3D-Printed Medicines for Rare Diseases, Discontinued Medicines, Drug Shortages and National Emergencies

The network is designed to bring together pharmacies, hospitals, contract manufacturers and government facilities to make personalized, rare disease, discontinued and short-supply medicines and emergency countermeasures, close to the patients who need them. Toronto, Ontario--(Newsfile Corp. - October 7, 2026) - PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) (the "Company" or "PharmaTher"), a specialty pharmaceutical company advancing 3D-printed medicines,
A minimalist illustration of a CHO cell and digital twin concept in flat design.

Oct 7, 2026

Hybrid Digital Twins Developed for Future Autonomous Labs

Researchers in South Korea are pioneering the development of a hybrid digital twin that integrates mechanistic modeling with artificial intelligence, aiming to create fully autonomous laboratories that require minimal human oversight.Led by Dong-Yup Lee, a professor at Sungkyunkwan University, the team is advancing a digital twin that stands apart from traditional models by being continuously connected to a multi-sensory system that gathers real-time data from bioreactors. This innovative approa
A vial of biopharmaceutical on a lab bench

Oct 7, 2026

Big Data Opportunities in Biomanufacturing

The integration of big data into biomanufacturing presents significant opportunities for enhancing predictive capabilities and operational efficiency within the industry.Research led by experts from the National Institute for Innovation in Manufacturing Biopharmaceuticals and the University of Delaware highlights the potential of leveraging extensive datasets from various operational domains—ranging from R&D to supply chain management. The findings stem from the MELLODDY Consortium, which involv
A minimalist representation of a data graph symbolizing machine learning.

Oct 7, 2026

Adding Low-Fidelity Data to ML Training Sets Could Yield Better Process Models

Integrating low-fidelity data with high-fidelity experimental information may enhance the accuracy of machine learning models in biopharmaceutical process development, as suggested by recent research.Machine learning holds promise for accelerating and optimizing biopharmaceutical processes by enabling predictions about the effects of parameter changes. However, the high-fidelity data necessary for training these models is costly and often scarce. Researchers propose that incorporating low-fideli
A minimalist illustration of a prescription bottle and a pill on a dark background.

Oct 7, 2026

New API Innovation Center index spotlights supply chain stress points

The newly launched National Fragility Index (NFI) by the API Innovation Center reveals significant vulnerabilities in the U.S. pharmaceutical supply chain, highlighting that over 550 million prescriptions filled this year are for drugs susceptible to disruptions.This index, introduced in collaboration with QYOBO, aims to assess and track risks associated with drug supply chains. It evaluated more than 400 medications across 131 treatment categories, identifying 14 drugs with severe fragility and
A bioreactor in a biopharmaceutical lab filled with cell culture medium.

Oct 7, 2026

Catalent wins access to Iro and launches next-gen development platform

Catalent is solidifying its position in next-generation drug development through a strategic partnership with Ori Biotech, aimed at accelerating the production of cell and gene therapies.This collaboration allows Catalent to join Ori’s Preferred Partner Network, which includes various academic medical centers and contract development and manufacturing organizations. By integrating Ori’s Iro platform, Catalent aims to enhance the efficiency of its development and manufacturing processes for autol
Press release cover image

Oct 7, 2026

LG CNS Showcases Pharma-Specific Manufacturing AX at World's Largest Pharma-Biotech Show

Participates in CPHI Milan 2026, Expanding Manufacturing AX Reach in PharmaShowcasing key solutions for factory design, production operations, and quality management using the theme "Autonomous Factory in Pharma"SEOUL, South Korea and MILAN, Oct. 7, 2026 /PRNewswire/ -- LG CNS, a leading AI Transformation company in Korea, is expanding its manufacturing AX business with a showcase of pharma-specific smart factory technologies at CPHI Milan 2026, the world's largest pharmaceutical and biotech exh